Skip to content

Mayville Engineering MEC Payments for finance leases

Payments for finance leases at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$300K+50.0%

Other financials

Income statement

See full
Revenue$144.8M+6.8%
Gross profit$11.0M-28.5%
Operating income-$7.7M-588%
Net income-$8.2M-40,975%
EPS (diluted)-$0.40

Balance sheet

See full
Cash & equivalents$2.1M+1,029%
Total debt$30.6M+5.5%
Total equity$232.2M-7.1%
Total assets$578.1M+29.1%

Cash flow

See full
Operating cash flow-$2.8M-133%
CapEx$4.2M+41.3%
Free cash flow-$6.9M-229%

Valuation

See full
Market cap$899.68M+175%
Enterprise value$928.24M+161%
P/S1.6×+1.0×

Profitability

See full
Gross margin8.9%-2.9pp
Operating margin-2.4%-9.3pp
Net margin-2.9%-7.0pp
FCF margin2.8%-10.7pp

Returns & leverage

See full
Return on equity-6.8%-16.2pp
Debt / equity0.1×0.0×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Mayville Engineering in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: Mayville Engineering’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mayville Engineering's payments for finance leases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mayville Engineering's payments for finance leases?
Mayville Engineering (MEC) reported payments for finance leases of $800K in Q1 2026.
How has Mayville Engineering's payments for finance leases changed year-over-year?
Mayville Engineering's payments for finance leases increased by 241.9% year-over-year, from $234K to $800K.
What is the long-term trend for Mayville Engineering's payments for finance leases?
Over 4 years (2021 to 2025), Mayville Engineering's payments for finance leases has grown at a 17.4% compound annual growth rate (CAGR), from $544K to $1.03M.
What does payments for finance leases mean?
Principal payments on finance lease obligations, reducing the lease liability on the balance sheet.